The daily business briefing: January 25, 2022
Stock turmoil continues after S&P 500 briefly falls into correction territory, Ford cuts off orders of Maverick pickups, and more

- 1. U.S. stocks bounced back from early Monday plunge, but volatility continues
- 2. Ford stops taking orders for Maverick pickups, citing high demand
- 3. Biden administration's free N95 masks begin arriving at pharmacies
- 4. Fed leaders head into 2-day meeting expected to signal March rate hike
- 5. Unilever unveils plan to cut 1,500 management jobs

1. U.S. stocks bounced back from early Monday plunge, but volatility continues
Markets fell dramatically early Monday but rallied later in the day, closing with modest gains. The S&P 500 fell briefly into correction territory, defined as 10 percent below its recent high, but closed up by 0.3 percent. The Dow Jones Industrial Average gained 0.3 percent, its first positive day in seven. The tech-heavy Nasdaq fell by 4.9 percent early Monday but ended the day up by 0.6 percent. Some analysts predicted that the market turbulence could continue as investors brace for more fallout from the Omicron coronavirus wave and rising interest rates. JPMorgan strategist Marko Kolanovic said the "recent pullback in risk assets appears overdone, and … we could be in the final stages of this correction." U.S. stock futures fell early Tuesday.
2. Ford stops taking orders for Maverick pickups, citing high demand
Ford is cutting off orders for its new Maverick pickup because of overwhelming demand. The company told dealers in a memo Monday that it would resume taking orders for the 2023 Maverick this summer. "We didn't want to take more orders than we could build," Dean Stoneley, general manager of Ford trucks, told The Wall Street Journal in an interview. "We're getting customers who would have perhaps bought a used car and are now buying the Maverick because it is so affordable." Prices for the Maverick start at about $20,000. Ford unveiled the new pickup last fall, as car prices were broadly rising.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Biden administration's free N95 masks begin arriving at pharmacies
The first free N95 masks sent out by the Biden administration started arriving in pharmacies around the country on Monday. The administration is distributing the high-quality masks as part of an effort to increase protection and testing to help slow the spread of the highly infectious Omicron variant of the coronavirus, which is fueling a wave of new COVID-19 cases. The arrival of the first of 400 million N95 masks the government is providing for the public came as free COVID-19 tests are arriving through the mail to people who ordered them. "Last week masks began shipping and arriving at pharmacies and grocers around [the] country. We expect that throughout the week the number of stores and N95s arriving to scale up significantly," an administration official said.
4. Fed leaders head into 2-day meeting expected to signal March rate hike
Federal Reserve policymakers on Tuesday start a two-day meeting that analysts expect to end Wednesday with a signal that the central bank plans to raise interest rates in March to fight high inflation. The Fed is expected to indicate that it plans to start tapering the asset purchases that, along with near-zero interest rates, it has been using to support the recovery from the economic damage of the coronavirus pandemic. The expectations of higher interest rates have roiled stocks recently, dragging down shares of tech companies and other high-growth stocks expected to be hit hardest by higher borrowing costs. U.S. Treasury yields rose early Tuesday ahead of the start of the Fed meeting.
5. Unilever unveils plan to cut 1,500 management jobs
Consumer goods giant Unilever on Tuesday said it would cut about 1,500 management jobs globally as it restructures in response to investor jitters over its failed $67 billion bid to acquire GlaxoSmithKline's consumer healthcare business. Unilever, which makes products from Dove soap to Magnum ice cream, has about 149,000 employees. The company said it would re-organize itself by creating five divisions focused on beauty and wellbeing, personal care, home care, nutrition, and ice cream, resulting in management-chain changes. "Moving to five category-focused business groups will enable us to be more responsive to consumer and channel trends, with crystal-clear accountability for delivery," Unilever CEO Alan Jope said.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Book reviews: ‘Red Scare: Blacklists, McCarthyism, and the Making of Modern America’ and ‘How to End a Story: Collected Diaries, 1978–1998’
Feature A political ‘witch hunt’ and Helen Garner’s journal entries
By The Week US Published
-
The backlash against ChatGPT's Studio Ghibli filter
The Explainer The studio's charming style has become part of a nebulous social media trend
By Theara Coleman, The Week US Published
-
Why are student loan borrowers falling behind on payments?
Today's Big Question Delinquencies surge as the Trump administration upends the program
By Joel Mathis, The Week US Published
-
Discount stores were thriving. How did they stumble?
The Explainer Blame Walmart — and inflation
By Joel Mathis, The Week US Published
-
Could a private equity deal be the end of Walgreens?
Today's Big Question The pharmacy chain will be taken private in a $10 billion deal
By Justin Klawans, The Week US Published
-
Eggs too pricey? Rent a chicken.
Under the Radar The cost of eggs increased more than 15% in January
By Justin Klawans, The Week US Published
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
By Peter Weber, The Week US Published
-
Will Trump's tariffs hurt Walmart?
Today's Big Question The world's biggest retailer 'isn't immune' to trade impacts
By Joel Mathis, The Week US Published
-
Store closings could accelerate throughout 2025
Under the Radar Major brands like Macy's and Walgreens are continuing to shutter stores
By Justin Klawans, The Week US Published
-
The diamond market is losing its shine
Under the radar Precious gemstones are rapidly dropping in price
By Devika Rao, The Week US Published
-
Can the US Steel-Nippon Steel merger come back to life?
Today's Big Question President Trump opposed the deal. But he could be flexible.
By Joel Mathis, The Week US Published